Diabetes Mellitus Clinical Trial
Official title:
Effectiveness of a Computerised Prompt for Primary and Secondary Care Physicians to Refer or Refer Back Type 2 Diabetes Patients
| Verified date | June 2015 |
| Source | UMC Utrecht |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Netherlands: Medical Ethics Review Committee (METC) |
| Study type | Interventional |
Patients with type 2 diabetes mellitus can receive care in the general practice or at the
outpatient clinic. In the region of Amersfoort in The Netherlands, primary care practices
and the hospital are connected through Diamuraal to organize the diabetes care in that
region. They work in the same electronic medical record, and patients can request access to
their own record (called a patient web portal). They set up Diamuraal guidelines, based on
the guidelines of the Dutch College of General Practitioners and Internists, on where the
patient care needs to be allocated (primary or secondary care), depending on the amount of
specific care a patient needs. Despite guidelines, not all patients are treated in the
correct place.
Our hypotheses is that when we improve triage we can cause a major shift from treatment in
secondary care to primary care and from primary care to self-care by using the patient web
portal. Furthermore, patients who needs extra attention due to problems with their diabetes
or complications can receive this extra attention due to increased e-consultation between
primary care and secondary care and if necessary actually can, during a short time, be
treated by an internist. We hope to achieve this by introducing a signal in the electronic
medical record. This signal allocates patients according to the guidelines and warns a
physician if their patients is not treated according to that guideline. The health care
provider can then discuss this situation with his patient. We believe that this leads to
shift in allocation of care, in which optimal care is provided and patients are made more
aware of their situation which hopefully leads to better self-management and satisfaction.
| Status | Completed |
| Enrollment | 2779 |
| Est. completion date | March 2015 |
| Est. primary completion date | October 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - patients with type 2 diabetes mellitus - health care provider work within Diamuraal setting Exclusion Criteria: - none |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Diamuraal-associated GP practices | Amersfoort | |
| Netherlands | Meander Medical Center | Amersfoort |
| Lead Sponsor | Collaborator |
|---|---|
| UMC Utrecht |
Netherlands,
Ronda MC, Dijkhorst-Oei LT, Gorter KJ, Beulens JW, Rutten GE. Differences between diabetes patients who are interested or not in the use of a patient Web portal. Diabetes Technol Ther. 2013 Jul;15(7):556-63. doi: 10.1089/dia.2013.0023. Epub 2013 Jun 18. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The number of participants with change in allocation of care after intervention | One of the following: shift from primary care to secondary care shift from secondary care to primary care continuation of treatment in primary care but with addition of e-consultation with secondary care continuation of treatment in primary care but with replacement of one or more office visits in self-control |
One year | No |
| Secondary | Assembly of reasons by health care providers for not following the guidelines | One year | No | |
| Secondary | Change in quality of diabetes care | Measured with Quality of Care and Outcomes in Type 2 Diabetes scoring system (QuED) containing scores for biomedical data (HbA1c, blood pressure, lipids, medication regimen, number of measurements) | One year | No |
| Secondary | Change in diabetes treatment satisfaction | Measured with the diabetes treatment satisfaction questionnaire (DTSQ): six questions on satisfaction with treatment regimen and two questions on perceived frequency of hyperglycemia and hypoglycemia. | One year | No |
| Secondary | Number of participants who meet their treatment goals | Measured in number of goals that are met | One year | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |